AbstractIntroductionAfter complete local excision of pT1 colorectal cancers, prediction of the absence of lymph-node involvement represents an interesting perspective in order to avoid unnecessary additional radical surgery, reducing morbidity, mortality and costs of care.We aimed to identify independent risk factors predictive of nodal involvement in pT1 colorectal cancer patients.MethodsData regarding depth of submucosal invasion, histological grading, tumour budding and lymphovascular invasion in a consecutive series of 48 pT1 surgically resected colorectal cancers have been retrospectively collected and related to the nodal status.ResultsA 12.5% rate of nodal involvement has been found. The poor differentiation was found as the only ind...
[[abstract]]Background: Approximately 10 percent of T1 colorectal cancer (CRC) has lymph node metast...
Worldwide, colorectal cancer (CRC) screening programs have significantly increased the detection of ...
Background & Aims: Risk stratification for adverse events, such as metastasis to lymph nodes, is bas...
Background and study aim: Population screening for colorectal cancer (CRC) is expected to increase t...
BACKGROUND The number of patients with colorectal cancers (CRCs) invading the submucosa (pT1) resec...
International audienceThe therapeutic management of patients with endoscopic resection of colorectal...
The International Collaboration on Cancer Reporting proposes histological tumour type, lymphovascula...
Through the implementation of national bowel cancer screening programmes we have seen a three-fold i...
Background & Aims: Most patients with pedunculated T1 colorectal tumors referred for surgery are not...
International audienceAssessment of the risk of lymph node invasion and tumour recurrence is critica...
BACKGROUND: The prediction of lymph node metastasis by current histopathological methods is imprecis...
PURPOSE: The estimation of regional lymph node metastasis (LNM) risk in T1 colorectal cancer is base...
The significance of nodal metastasis as a prognostic factor in colorectal cancer is universally reco...
__Aims:__ Changes in rectal cancer treatment include increasing emphasis on organ preservation. Loca...
Worldwide, colorectal cancer (CRC) screening programs have significantly increased the detection of ...
[[abstract]]Background: Approximately 10 percent of T1 colorectal cancer (CRC) has lymph node metast...
Worldwide, colorectal cancer (CRC) screening programs have significantly increased the detection of ...
Background & Aims: Risk stratification for adverse events, such as metastasis to lymph nodes, is bas...
Background and study aim: Population screening for colorectal cancer (CRC) is expected to increase t...
BACKGROUND The number of patients with colorectal cancers (CRCs) invading the submucosa (pT1) resec...
International audienceThe therapeutic management of patients with endoscopic resection of colorectal...
The International Collaboration on Cancer Reporting proposes histological tumour type, lymphovascula...
Through the implementation of national bowel cancer screening programmes we have seen a three-fold i...
Background & Aims: Most patients with pedunculated T1 colorectal tumors referred for surgery are not...
International audienceAssessment of the risk of lymph node invasion and tumour recurrence is critica...
BACKGROUND: The prediction of lymph node metastasis by current histopathological methods is imprecis...
PURPOSE: The estimation of regional lymph node metastasis (LNM) risk in T1 colorectal cancer is base...
The significance of nodal metastasis as a prognostic factor in colorectal cancer is universally reco...
__Aims:__ Changes in rectal cancer treatment include increasing emphasis on organ preservation. Loca...
Worldwide, colorectal cancer (CRC) screening programs have significantly increased the detection of ...
[[abstract]]Background: Approximately 10 percent of T1 colorectal cancer (CRC) has lymph node metast...
Worldwide, colorectal cancer (CRC) screening programs have significantly increased the detection of ...
Background & Aims: Risk stratification for adverse events, such as metastasis to lymph nodes, is bas...